| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/21/2007 | CN1305473C Rubitecan containing formulation for injection |
| 03/21/2007 | CN1305472C Medical compsns. against helicobacter pylori |
| 03/21/2007 | CN1305471C Use of sophoridine oxide in preparing anticancer medicine |
| 03/21/2007 | CN1305470C Process for preparing a finely self-emulsifiable pharmaceutical composition |
| 03/21/2007 | CN1305469C Use of levo-ornidazole for preparing anti-parasitic-infectious drug |
| 03/21/2007 | CN1305468C Bolengsu compound and its preparation, medicine composition and use |
| 03/21/2007 | CN1305467C Zinc containing compositions for anti-viral use |
| 03/21/2007 | CN1305466C Application of Cytospora bacterin B in preparation of antineoplastic medicine |
| 03/21/2007 | CN1305465C Cell growth regulating factor I and its preparation process |
| 03/21/2007 | CN1305464C Temperature-reducing refreshing aerosol |
| 03/21/2007 | CN1305462C Diffusional implantable delivery system |
| 03/21/2007 | CN1305460C Sugar intake promoters |
| 03/21/2007 | CA2547216A1 Process for annealing amorphous atorvastatin |
| 03/20/2007 | US7193126 Method for generating overexpression of alleles in genes of unknown function |
| 03/20/2007 | US7193111 For conditioning the skin and hair |
| 03/20/2007 | US7193108 Phenylpropionic acid derivatives |
| 03/20/2007 | US7193084 Crystal structure determined by differential scanning calorimetry and infrared analysis |
| 03/20/2007 | US7193083 Preparation of triazoles by organometallic addition to ketones and intermediates therefor |
| 03/20/2007 | US7193081 Process for preparation of cyclic prodrugs of PMEA and PMPA |
| 03/20/2007 | US7193077 Forming an internucleotide bond by contacting a nucleoside moiety having a reactive site hydroxyl with a precursor having an exocyclic amine triaryl protecting group; solid phase synthesis; by-product inhibition; greater monomer solubility in anhydrous solvents |
| 03/20/2007 | US7193075 Sequences upstream of the CARP gene, vectors containing them and uses thereof |
| 03/20/2007 | US7192984 Compositions of polyacids and polyethers and methods for their use as dermal fillers |
| 03/20/2007 | US7192983 N-protected/N-substituted-beta-amino hydroxy sulfonates |
| 03/20/2007 | US7192982 Modulators of peroxisome proliferator activated receptors |
| 03/20/2007 | US7192981 Naphthalene methyl ester derivatives for treatment of diabetes; insulin receptor signalling |
| 03/20/2007 | US7192980 Such as 6-[14-[(aminocarbonyl)oxy]-2,6,12-trihydroxy-5,7,9,11,13,15-hexamethyl-3,8,16,18-nonadecatetraenyl]tetrahydro-(6R)-2H-pyran-2-one; high selectivity; colon cancer |
| 03/20/2007 | US7192979 EP4 receptor selective agonist in the treatment of osteoporosis |
| 03/20/2007 | US7192978 Pyrrolidinium derivatives |
| 03/20/2007 | US7192977 Duocamycin prodrugs; binding to Dna |
| 03/20/2007 | US7192976 3-substituted pyrazoles; cell proliferation and angiogenesis promoters; antiapoptotosis and antifibrosis activity |
| 03/20/2007 | US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof |
| 03/20/2007 | US7192974 Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents |
| 03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/20/2007 | US7192972 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; piperidin-2-amide derivatives; anticarcinogenic agents |
| 03/20/2007 | US7192971 4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/20/2007 | US7192970 Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 03/20/2007 | US7192969 Ester derivatives |
| 03/20/2007 | US7192968 Ethylenediamine derivatives |
| 03/20/2007 | US7192967 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 03/20/2007 | US7192966 Pharmaceutical composition |
| 03/20/2007 | US7192965 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
| 03/20/2007 | US7192964 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | US7192962 Enzyme hydrolase inhibitors such as 1-ethyl-3,7-dihydro-8-((1 R,2R)-(hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-7-((3-bromo-4 -methoxyphenyl)methyl)-1H-Purine-2,6-dione, used for physiological effects |
| 03/20/2007 | US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 03/20/2007 | US7192960 Sodium channel blockers |
| 03/20/2007 | US7192959 Sodium channel blockers |
| 03/20/2007 | US7192958 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders |
| 03/20/2007 | US7192957 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS |
| 03/20/2007 | US7192956 Inducing contraception by delivering to a female of child-bearing age a selective estrogen receptor modulator comprising cyclothiocarbamate derivative |
| 03/20/2007 | US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/20/2007 | US7192954 Calcitonin Gene-Related Peptide (CGRP) antagonists for migraine and cluster headaches; 5'-acylamino-spiro[imidazolidine-4,2'-indane]-2,5-dione derivatives |
| 03/20/2007 | US7192953 Antibacterial agents |
| 03/20/2007 | US7192952 2,6-Dioxo-1,2,3,6-tetrahydropurine derivatives; dipeptidyl peptidase IV inhibitors for diabetes and obesity |
| 03/20/2007 | US7192951 Administering mixture of diuretic and vasopressin antagonist comprising furosemide and conivaptan; increasing water excretion and decreasing sodium and potassium excretion |
| 03/20/2007 | US7192950 Psychological disorders; eating disorders; dietetics |
| 03/20/2007 | US7192949 Anticarcinogenic and antiproliferative agents |
| 03/20/2007 | US7192948 Bicyclic heterocycles as HIV integrase inhibitors |
| 03/20/2007 | US7192947 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 03/20/2007 | US7192946 Hyperlipemia agents; bile acid transport inhibitors |
| 03/20/2007 | US7192945 Benzothiazepine derivatives |
| 03/20/2007 | US7192944 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 03/20/2007 | US7192943 Cephem compounds |
| 03/20/2007 | US7192942 Wet milling while crystallizing to obtain a primary particle suspension. |
| 03/20/2007 | US7192941 Estradiol metabolites for the treatment of pulmonary hypertension |
| 03/20/2007 | US7192940 Ether compounds |
| 03/20/2007 | US7192939 A biologically pure culture of Pestalotiopsis microspora strain 12-30 characterized by possessing antioxidant and antifungal activities in culture media, and containing 1,5,7 trisubstituted 1,3-dihydroisobenzofurans |
| 03/20/2007 | US7192938 Orally administered risedronic acid or salt for osteoporosis or bone disorder treatment |
| 03/20/2007 | US7192937 Disinfecting amount of stearyl dihydroxypropyldimonium oligosaccharide in ophthalmicaqueous solution; aminoalcohol buffer and tonicity agent |
| 03/20/2007 | US7192936 Use treating hepatitis C infection optionally with other viricides such as interferons or ribavirin; low toxicity to the host; use of cytosine-based nucleotides or nucleosides having a 2'-trifluoromethyl-ribose moiety which forms a 5'-phosphate or hydroxy moiety in vivo |
| 03/20/2007 | US7192934 Nucleic acid polypeptide that induces an immune response; malaria |
| 03/20/2007 | US7192933 Use of a baculovirus to express an exogenous gene in a mammalian cell |
| 03/20/2007 | US7192932 Use of immunomodulating agents |
| 03/20/2007 | US7192931 Treatment of demyelinating diseases |
| 03/20/2007 | US7192928 T cell antigen receptor peptides |
| 03/20/2007 | US7192776 mixture of water, creatinine, biocides and optionally urea, having controlled pH and specific gravity, used in urinalysis |
| 03/20/2007 | US7192743 applying solutions comprising culture broths containing teicoplanin, from Actinoplanes teichomyceticus strains capable of producing teicoplanin, to porous adsorption resins, then eluting, treating with activated carbon to recover the teicoplanin andultrafiltration; purification |
| 03/20/2007 | US7192742 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages |
| 03/20/2007 | US7192735 Phosphopantetheinyl transferases and uses thereof |
| 03/20/2007 | US7192706 Growth regulating proteins |
| 03/20/2007 | US7192705 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss |
| 03/20/2007 | US7192614 Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
| 03/20/2007 | US7192612 Prophylaxis, prevention, therapy for cancer |
| 03/20/2007 | US7192611 Administering a Free-B-Ring flavonoid as cyclooxygenase-2 (COX-2) inhibitor to treat osteoarthritis, rheumatoid arthritis, menstrual cramps, Systemic Lupus Erythromatosis, psoriasis, migraines, inflammatory bowel disease, cancer |
| 03/20/2007 | US7192609 Administering to the gastrointestinal tract salt of a rare earth metal and one or more nontoxic counterions, which salt is hydrated, in an amount effective to inhibit the absorption of oxalate from the gastrointestinal tract |
| 03/20/2007 | US7192607 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities |
| 03/20/2007 | US7192606 carbocyclic imidodisulfamide compounds; preferably but not limited to infections caused by orthopox viruses |
| 03/20/2007 | US7192605 Composition for use in the efficient transfer of nucloetide sequences into cells |
| 03/20/2007 | US7192597 comprising fatty compound, quaternary ammonium compound and S-adenosylmethionine |
| 03/20/2007 | US7192586 Topical administration of an anti-PSMA antibody alone or conjugated to a cytotoxic moiety to the extracellular domain of human prostate specific membrane antigen (PSMA); anti-proliferative agents and - carcinogenic agents |
| 03/20/2007 | US7192583 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures |
| 03/20/2007 | US7192578 By administering antiinflammatory drugs |
| 03/20/2007 | US7192572 Compound delivery systems |
| 03/20/2007 | CA2438768C Improved flexible collodion compositions |
| 03/20/2007 | CA2433518C Method for producing the anticholinergic tiotropium bromide |
| 03/20/2007 | CA2411787C Stable gabapentin having ph within a controlled range |
| 03/20/2007 | CA2364845C Extending the duration of drug release within the stomach during the fed mode |
| 03/20/2007 | CA2360655C Pharmaceutical compositions |
| 03/20/2007 | CA2360524C Reduction of hair growth |
| 03/20/2007 | CA2315115C Compositions of microspheres for wound healing |